Skip to content
10-K

Annual Report

Evolutionary Genomics, Inc.

0001553350-21-000252

← back to feed
Filed
Mar 31, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Dec 31, 2020 5.88M sh
Net Income FY 2020 · Dec 31, 2020 −$1.71M
Net Income FY 2020 · Sep 30, 2020 $535.89K
Net Income FY 2020 · Jun 30, 2020 −$294.8K
Net Income FY 2020 · Mar 31, 2020 −$241.82K
Net Income FY 2020 · Dec 31, 2019 −$232.11K
Net Income FY 2020 · Dec 31, 2019 −$793.14K
Net Income FY 2020 · Sep 30, 2019 −$162.87K
Net Income FY 2020 · Jun 30, 2019 −$189.36K
Net Income FY 2020 · Mar 31, 2019 −$208.8K
Operating Cash Flow FY 2020 · Dec 31, 2019 −$625.98K
Short Term Investments FY 2020 · Dec 31, 2019 $41.69K
Cash And Equivalents FY 2020 · Dec 31, 2019 $45.44K
Cash And Equivalents FY 2020 · Dec 31, 2018 $131.41K
Current Liabilities FY 2020 · Dec 31, 2019 $19.42K
Total Liabilities FY 2020 · Dec 31, 2019 $1.01M
Current Assets FY 2020 · Dec 31, 2019 $118.16K
Total Assets FY 2020 · Dec 31, 2019 $4.24M
Sga Expense FY 2020 · Dec 31, 2019 $219.07K
Rd Expense FY 2020 · Dec 31, 2019 $472.61K
Operating Income FY 2020 · Dec 31, 2019 −$774.83K
Revenue FY 2020 · Dec 31, 2019 $122.69K
Stockholders Equity FY 2020 · Sep 30, 2019 −$135.61K
Stockholders Equity FY 2020 · Jun 30, 2019 $27.27K
Stockholders Equity FY 2020 · Mar 31, 2019 $212.07K
Stockholders Equity FY 2020 · Dec 31, 2018 $403.59K